|
|
||||||||
Ann Thorac Surg 2006;82:1807
© 2006 The Society of Thoracic Surgeons
University of Modena and Reggio Emilia, Division of Thoracic Surgery, Largo del Pozzo 71, 41100 Modena, Italy
(Email: morandi.uliano@unimo.it).
| The first 20% of the full text of this article appears below. |
Interest in the treatment of pulmonary large cell neuroendocrine carcinoma (LCNEC), a relatively uncommon tumor, has been growing among chest physicians in recent years. It is now accepted that this high-grade neuroendocrine tumor is associated with a poor prognosis after surgical resection, even in the early stages, with survival results significantly worse than stage-comparable conventional non-small cell lung carcinoma.
Some evidence supports the hypothesis of a similarity between LCNEC and small cell lung carcinoma (SCLC).
Related Article
Ann. Thorac. Surg. 2006 82: 1802-1807.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |